Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT04690972 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT04690972
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with chronic liver disease (whether caused by a virus or another reason)
  • People who have at least one liver nodule (a growth or lump on the liver) and are already scheduled to have a biopsy of it as part of their normal medical care
  • People who are already scheduled to have liver surgery as part of their normal medical care
  • People who have been recommended a local treatment (a treatment directed at the liver area) for a type of liver cancer called HCC, as part of their normal medical care
  • People who are able to receive and understand information about the study and are willing to sign a written consent form
  • People who are enrolled in the French social security system

Who may not be able to join:

  • People who are under 18 years of age
  • People who are under any form of legal protection (confirm with trial site)
  • People who are unable to give their own consent
  • People who are in a situation of social vulnerability or hardship (confirm with trial site)
  • Women who are pregnant or breastfeeding
  • People who have not signed the informed consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 68 85 37 03

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Registry
ClinicalTrials.gov
Start date
14 January 2021
Est. completion
18 January 2021

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Surgery for a hepato-bilio-pancreatic issue

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov